SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015261
Filing Date
2023-04-27
Accepted
2023-04-27 16:06:04
Documents
5
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A amlx-def14a-2023-proxy.htm DEF 14A 1295159
2 GRAPHIC img11283999_0.jpg GRAPHIC 103455
3 GRAPHIC img11283999_1.jpg GRAPHIC 103455
4 GRAPHIC img11283999_2.jpg GRAPHIC 315730
5 GRAPHIC img11283999_3.jpg GRAPHIC 353134
  Complete submission text file 0000950170-23-015261.txt   2475563
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41199 | Film No.: 23856810
SIC: 2834 Pharmaceutical Preparations